Delivery Order SPE2DX22D0010-SPE2D823FCW00
Award Date 1/12/23
Potential Completion Date 1/13/23
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,667.60, is a delivery order for the supply of ZENZEDI 20 MG TABLET 30S, a medication product. The contract has a firm fixed price pricing type and a completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.44, is a delivery order for the supply of Zenzedi 20 mg tablets. It is a firm fixed-price contract with a performance period ending on May 12, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is the prime contractor, and there is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,949.90 to AmerisourceBergen Drug Corp for Zenzedi tablets 20mg on August 13, 2025, with a completion date of August 14, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,923.66 on October 29, 2025, for the supply of Zenzedi tablets 15mg under a firm fixed price contract. The award, which is set to be completed by October 30, 2025, was issued by the Medical Supply Chain division of the Defense Logistics Agency without a set-aside designation, indicating the contract was competitively awarded. This delivery order is...
- The Department of Defense awarded AmerisourceBergen Drug Corp a delivery order valued at $5,699.16 for Zenzedi tablets (20mg) under a firm fixed-price contract with an ultimate completion date of November 14, 2025. This non-set-aside competitive award supports the Medical Supply Chain, a Defense Logistics Agency component responsible for pharmaceutical procurement across military healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,392.96 contract is for the delivery of Zenzedi (dextroamphetamine) 15mg tablets, a prescription medication. The contract has an ultimate completion date of July 7, 2025 and is not a set-aside award. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,084.10 delivery order to AmerisourceBergen Drug Corp for 15mg Zenzedi tablets, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and utilizes AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) for Zenzedi 20 mg tablets valued at $1,636.38 with a firm fixed price contract type. The award was issued on October 15, 2025, with an ultimate completion date of October 16, 2025, and the place of performance is located in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the procurement of a wide range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to support military healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,105.65 firm-fixed-price delivery order is for the supply of the medication ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. The IDC enables the government to...